Kawasaki syndrome: role of superantigens revisited.
Donald Y M LeungPatrick M SchlievertPublished in: The FEBS journal (2020)
Kawasaki syndrome (KS) is an acute vasculitis in children complicated by the development of heart disease. Despite its description over 50 years ago, the etiology of coronary artery disease in KS is unknown. High dose intravenous immunoglobulin is the most effective approach to reduce cardiovascular complications. It remains unclear why patients with KS develop coronary artery aneurysms. A subset of patients is resistant to immunoglobulin therapy. Given the heterogeneity of clinical features, variability of history, and therapeutic response, KS may be a cluster of phenotypes triggered by multiple infectious agents and influenced by various environmental, genetic, and immunologic responses. The cause of KS is unknown, and a diagnostic test remains lacking. A better understanding of mechanisms leading to acute KS would contribute to a more precision medicine approach for this complex disease. In the current viewpoint, we make the case for microbial superantigens as important causes of KS.
Keyphrases
- high dose
- coronary artery
- coronary artery disease
- liver failure
- end stage renal disease
- chronic kidney disease
- respiratory failure
- newly diagnosed
- low dose
- drug induced
- prognostic factors
- pulmonary hypertension
- genome wide
- risk factors
- percutaneous coronary intervention
- cardiovascular disease
- acute coronary syndrome
- stem cells
- dna methylation
- type diabetes
- patient reported outcomes
- single cell
- peritoneal dialysis
- climate change
- risk assessment